Download presentation
Presentation is loading. Please wait.
Published byWesley Daniel Modified over 5 years ago
1
Impact of Solid Minor Histologic Subtype in Postsurgical Prognosis of Stage I Lung Adenocarcinoma
Tianxiang Chen, MD, PhD, Jizhuang Luo, MD, Haiyong Gu, MD, Yu Gu, MD, Qingyuan Huang, MD, Yiyang Wang, MD, Jiajie Zheng, MD, Yunhai Yang, MD, Haiquan Chen, MD The Annals of Thoracic Surgery Volume 105, Issue 1, Pages (January 2018) DOI: /j.athoracsur Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Survival curves for (A) disease-free survival and (B) overall survival for stage I invasive lung adenocarcinoma patients according to the eighth TNM staging (p values from log rank test): lepidic (LEP) (green lines); acinar (ACN) (blue lines); papillary (PAP) (purple line); micropapillary (MIP) (gold lines); and solid (SOL) (red lines). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Survival curves for (A, C) disease-free survival and (B, D) overall survival according to percentage of solid (S) component presented in tumor tissue. Survival curves for (A, B) stage IA patients and (C, D) stage IB patients according to eighth TNM staging project (p values from log rank test). Green lines indicate solid absent; blue lines indicate solid minor; and red lines indicate solid predominant. (vs. = versus.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions
4
Fig 3 Survival curves for (A, C) disease-free survival and (B, D) overall survival according to treatment arm—adjuvant chemotherapy (blue lines) versus surgery alone (red lines)—of patients in (A, B) solid predominant group and (C, D) solid minor group (p values from log rank test). (ACT = adjuvant chemotherapy; CI = confidence interval; HR = hazard ratio.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.